Formulate Draft Guidelines For Facilitating Compensation Disbursement Process And Expedition Of Cases Before MACT: SC To Insurance Company

first_imgNews UpdatesFormulate Draft Guidelines For Facilitating Compensation Disbursement Process And Expedition Of Cases Before MACT: SC To Insurance Company Nupur Thapliyal13 Feb 2021 2:13 AMShare This – xThe Supreme Court on Wednesday directed the Bajaj Allianz General Insurance Company, the petitioner in the matter, to come up with draft guidelines for facilitating compensation disbursement process and expedition of cases before Motor Accidents Claims Tribunal (MACT). The direction came by a bench comprising of Justices S.K. Kaul, Dinesh Maheshwari and Hrishikesh Roy. Senior Advocate…Your free access to Live Law has expiredTo read the article, get a premium account.Your Subscription Supports Independent JournalismSubscription starts from ₹ 599+GST (For 6 Months)View PlansPremium account gives you:Unlimited access to Live Law Archives, Weekly/Monthly Digest, Exclusive Notifications, Comments.Reading experience of Ad Free Version, Petition Copies, Judgement/Order Copies.Subscribe NowAlready a subscriber?LoginThe Supreme Court on Wednesday directed the Bajaj Allianz General Insurance Company, the petitioner in the matter, to come up with draft guidelines for facilitating compensation disbursement process and expedition of cases before Motor Accidents Claims Tribunal (MACT). The direction came by a bench comprising of Justices S.K. Kaul, Dinesh Maheshwari and Hrishikesh Roy. Senior Advocate Meenakshi Arora appeared on behalf of the petitioner company along with Adv. Siddharth, AOR. The petitioner sought slew of directions from the Apex Court in order to facilitate the process of disbursement of compensation as well as expediting the matter before the MACT. In the previous hearing before the same bench dated 18.01.2021, the bench directed the petitioner to submit a note indicating the directions within 10 days. During the course of proceedings today, Meenakshi Arora informed the bench that she had submitted the required note in the Court wherein she had incorporated various directions given by the Delhi High Court and other High Courts across India dealing with compensation disbursement process and expedition of cases pending before MACT. However, Justice Kaul clarified Ms. Arora that the bench had asked the petitioner to prepare “draft directions” for the Court to look into the aspect of its implementation. Ms. Arora, accepting her fault for not submitting the requisite draft directions, sought permission from the bench to grant some time to the petitioner to come up with the guidelines. “You cannot put everything on court and say you do it. You should have framed the guidelines. You’ve not done the exercise.” Justice Kaul remarked at the outset. “We asked you vide Order dated 18th January for directions related to disbursement of compensation and expedition of MACT cases, which would have then modulated for a uniform application. We are trying to help you out. We will give you one more chance. Otherwise we will close this case.” The bench observed. The bench granted one last chance to the petitioner in order to come up with the draft guidelines. However, in doing so, the bench also ordered that if the petitioner fail to come up with the guidelines in the next date of hearing, it will mean that the insurance company is not interested in the passing of directions.”We have seen the application and the notes submitted by the petitioner but in the course of proceedings, it has been impressed upon learned senior counsel for the petitioner that this is not what we had in mind when we passed the directions on 18.01.2021 and thus, if the insurance company is interested in the slew of directions, the same be set forth in the manner which we have indicated in the Court failing which we will presume that the insurance Company is not interested.” The order said.The matter will now be heard on 24th February 2021.Click Here To Download OrderOrder Dated 18.01.2021 Can Be Read HereNext Storylast_img read more

Press release: Expert partnership to explore and establish Human Challenge studies of COVID-19 in the UK

first_img This investment will accelerate the development of potentially life-saving vaccines to help get them to the public more quickly. Experts from the NHS, academia and the private sector are today (20 October) joining forces with the government to explore and establish human challenge trials in the UK to speed up the development of a COVID-19 vaccine.In human challenge studies, a vaccine candidate that has proven to be safe in initial trials is given to a small number of carefully selected healthy adult volunteers who are then exposed to the virus in a safe and controlled environment. Medics and scientists then closely monitor the effect on volunteers 24 hours per day to see exactly how the vaccine works and to identify any side effects.As with all clinical studies in the UK, the proposed research will be carefully considered by regulators including the Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS Health Research Authority through research ethics committees before any research starts.Using controlled doses of virus, the aim of the research team  will initially be to discover the smallest amount of virus it takes to cause COVID-19 infection in small groups of healthy young people, aged between 18 and 30, who are at the lowest risk of harm. Up to 90 volunteers, who are compensated for the time they spend in the study, could be involved at this stage.Human challenge studies offer the chance to accelerate development of promising vaccines against COVID-19, bringing them to people more quickly – potentially saving thousands of lives.The studies are conducted under strict conditions – these include a controlled entrance to the facility, careful decontamination of waste and a dedicated laboratory for carrying out tests, all of which help to ensure the study is delivered safely and securely. All the air leaving the unit is also cleaned so there is no risk to anyone outside the unit.Over many decades, human challenge studies have been performed safely and have played important roles in accelerating the development of treatments for diseases including malaria, typhoid, cholera, norovirus and flu. The trials have also helped researchers establish which possible vaccine is most likely to succeed in phase 3 clinical trials that would follow, usually involving thousands of volunteers.If approved by regulators and the ethics committee, the studies would start in January with results expected by May 2021.Business Secretary Alok Sharma said: We are proud to be part of this hugely important partnership which we hope will advance the world’s understanding of COVID-19 as we look to rapidly develop life-saving treatments. The Royal Free Hospital has a great history and tradition of treating and researching infectious diseases and our centre is renowned across the world for its work in this specialist area. We are looking forward to working alongside Imperial College London, BEIS, and hVIVO on such a vital piece of work over the coming months. Head of Vaccine Research Projects at PHE Porton Down, Bassam Hallis said: This research will improve understanding of the virus, the biology of the disease, the signs that a person is protected from infection or developing the disease, the vaccine candidates, and will help in making decisions about research, that it is carried out safely and based on up-to-date evidence. There is much we can learn in terms of immunity, the length of vaccine protection, and reinfection. Deputy Chief Medical Officer Professor Jonathan Van-Tam said: Dr Chris Chiu, from the Department of Infectious Disease at Imperial College London and lead researcher on the human challenge study, said: Human challenge studies can increase our understanding of COVID-19 in unique ways and accelerate development of the many potential new COVID-19 treatments and vaccines. Our number one priority is the safety of the volunteers. My team has been safely running human challenge studies with other respiratory viruses for over 10 years. No study is completely risk free, but the Human Challenge Programme partners will be working hard to ensure we make the risks as low as we possibly can. The UK’s experience and expertise in human challenge trials as well as in wider coronavirus science will help us tackle the pandemic, benefiting people in the UK and worldwide. This investment into new facilities at PHE Porton Down will enable its dedicated and expert scientists to accelerate the pace and scale of specialised testing to support the critical work of the Vaccine Taskforce. New research will explore the potential for new studies to accelerate development of a COVID-19 (coronavirus) vaccine £33.6 million government investment will back the studies in partnership with Imperial College London, hVIVO and the Royal Free London NHS Foundation Trust a further £19.7 million will scale up capabilities to process blood samples from clinical trials Executive Chairman of Open Orphan, hVIVO’s parent company, Cathal Friel said:center_img Implementing Human Challenge studiesWhen strict conditions are met, there is global agreement through the WHO that human challenge studies can bring important wider societal benefits which should be considered by research ethics committees.  The first stage of this project will be delivered by a partnership between Imperial College London, the Royal Free Hospital’s specialist and secure research unit in London and industry-leading clinical company hVIVO, which has pioneered viral human challenge models.The aim will be to discover the smallest amount of virus it takes to cause a person to develop COVID-19 infection. This is known as a virus characterisation study and will be backed by £33.6 million of government investment.The study will take place in world-class clinical facilities at the Royal Free specifically designed to contain the virus. Highly trained medics and scientists will be on hand to carefully examine how the virus behaves in the body and to ensure volunteer safety. Volunteers will be monitored for up to a year after participating in the study to ensure their long-term well-being.Once this first phase is completed, researchers will deploy this human challenge model which will provide an unrivalled opportunity to study closely how vaccines work in the body to stop COVID-19.Although other countries are considering human challenge studies for COVID-19, the UK is a leading country in the science behind and the delivery of these studies and will be the first to seek to establish them, with the necessary infrastructure and skilled workforce already in place.  It comes as the government is also investing £19.7 million in Public Health England (PHE) to scale up its capabilities in testing blood samples from clinical trials. The investment will fund vital equipment and a new, state-of-the-art laboratory facility at PHE Porton Down – this will accelerate essential testing to measure the effectiveness of COVID-19 vaccines currently in development. These tests are an essential component in supporting the development and regulatory approval of vaccine candidates. PHE’s partner, Nexelis, will be providing scientific expertise and also conducting additional testing for the evaluation of COVID-19 vaccines.The new investment will enable PHE Porton Down scientists to increase testing capacity, including evaluating individuals’ immune responses as part of the Human Challenge project.Innovation Minister Lord Bethell said: procuring the rights to a diverse range of promising vaccine candidates to spread risk and optimise chances for success providing funding for clinical studies, diagnostic monitoring and regulatory support to rapidly evaluate vaccines for safety and efficacy providing funding and support for manufacturing scale-up and fill and finish at risk so that the UK has vaccines produced at scale and ready for administration should any of these prove successful Chair of the government’s Vaccine Taskforce Kate Bingham said: A safe, fully approved, and meticulously controlled human challenge model for COVID-19 that is conducted by experienced experts may help in the search for safe and effective vaccines. First, for the many vaccines still in the mid-stages of development, human challenge studies may help pick out the most promising ones to take forward into larger Phase III trials. Second, for vaccines which are in the late stages of development and already proven to be safe and effective through Phase III studies, human challenge studies could help us further understand if the vaccines prevent transmission as well as preventing illness. At Open Orphan we are pleased to be working on behalf of the UK government and in partnership with 2 great institutions, Imperial College London and The Royal Free Hospital. Our subsidiary hVIVO is the world leader in the testing of vaccines and antivirals using human challenge studies and our contract with the UK government to develop a COVID-19 human challenge study model will safely accelerate the discovery of effective vaccines and antivirals against COVID-19. We hope our work will not just be valuable for the Company but will also help to reduce the impact of COVID-19 on the population. Our thoughts go out to all those that have been affected by the global COVID-19 pandemic. Chief Executive of the Royal Free London group Caroline Clarke said: About Public Health EnglandPHE exists to protect and improve the nation’s health and wellbeing and reduce health inequalities. It does this through world-leading science, research, knowledge and intelligence, advocacy, partnerships and the delivery of specialist public health services. PHE is an operationally autonomous executive agency of the Department of Health. It provides government, local government, the NHS, Parliament, industry and the public with evidence-based professional, scientific and delivery expertise and support. For more information on PHE visit or follow on Twitter. We are doing everything we can to fight coronavirus, including backing our best and brightest scientists and researchers in their hunt for a safe and effective vaccine. The funding announced today for these ground-breaking but carefully controlled studies marks an important next step in building on our understanding of the virus and accelerating the development of our most promising vaccines which will ultimately help in beginning our return to normal life. Notes to editorsHuman challenge studies have been performed safely over several decades in thousands of consenting volunteers in other disease areas such as typhoid, cholera, and influenza. They differ from standard clinical trials in which volunteers are vaccinated to see if they develop a disease circulating in the community over several months. In human challenge studies, a smaller group of volunteers is exposed to an infection after they have been vaccinated.About the government’s Vaccine TaskforceThe government’s Vaccine Taskforce (VTF) was set up under the Department for Business, Energy and Industrial Strategy (BEIS) in May 2020, to ensure that the UK population has access to clinically effective and safe vaccines as soon as possible, while working with partners to support international access to successful vaccines.  This is to place the UK at the forefront of global vaccine research, development, manufacture and distribution.The Vaccine Taskforce comprises a dedicated team of private sector industry professionals and officials from across government who are working at speed to build a portfolio of promising vaccine candidates that can end the global pandemic. It is chaired by biotech and life sciences expert Kate Bingham, who was appointed by the Prime Minister Boris Johnson.The Vaccine Taskforce’s approach to securing access to vaccines is through:last_img read more

Andy Murray faces tricky draw in singles return at Cincinnati Masters

first_imgHaving accepted a wild card into the ATP Masters 1000 event, Murray — a three-time Grand Slam champion — is facing a tough run.Murray will face Richard Gasquet in the opening round and he holds an 8-3 win-loss record over the Frenchman. Related News Serena Williams dominates Naomi Osaka in first meeting since US Open final Andy Murray to make singles return at Cincinnati Masters Andy Murray has been handed a tricky draw for his singles return at the Cincinnati Masters.The former world No. 1 is making his comeback in singles just over six months after undergoing hip resurfacing surgery and having returned in doubles.center_img If the two-time Cincinnati champion can win his opener, Murray will face fourth seed Dominic Thiem, while the Brit is in the same quarter as Alexander Zverev and half as Rafael Nadal.Cincy’s where the magic happens See you in the singles draw, @andy_murray— Western & Southern Open (@CincyTennis) August 9, 2019Murray last played singles at the Australian Open, losing to Roberto Bautista Agut in the first round, and at the time suggested he was facing retirement.However, Murray described his latest operation, which has left him pain-free, as “life-changing” and he is now on the brink of completing a remarkable return to top-level singles action. Last year’s finalists, champion Novak Djokovic and runner-up Roger Federer, are returning to action in Cincinnati for the first time since Wimbledon. Both have first-round byes in the elite 64-player event. Among high-profile U.S. players in the draw, 13th seed John Isner opens against Dusan Lajovic and Frances Tiafoe faces Gael Monfils.last_img read more

Minnesota’s QB Says Michigan State Has Big Ten’s Worst Visiting Locker Room

first_imgMichigan State's Spartan Stadium during the spring game.InstagramGoing on the road in the Big Ten is never a treat – between the travel, the team’s opposing fans and the shoddy facilities. But according to Minnesota quarterback Mitch Leidner, one program’s visiting locker room situation is worse than the rest.Leidner was asked which program has the worst locker room in the Big Ten, and his answer was Michigan State. He claims the stalls don’t have doors. Andy Greder of the St. Paul Pioneer Press captured the quote.#Gophers QB Mitch Leidner was asked today about worst #B1G visiting locker room. Michigan State, he said. Reason: no doors on toilet stalls.— Andy Greder (@andygreder) July 26, 2016It’s hard to disagree with Leidner, if what he’s saying is true.Luckily for Leidner, he won’t have to deal with the situation again. He’s a senior, and Minnesota doesn’t play Michigan State in 2016.last_img read more

Business Highlights

first_img___US hiring slower but steady as employers add 155K jobsWASHINGTON (AP) — U.S. employers pulled back on hiring in November, adding just 155,000 jobs. That’s below this year’s average monthly gains but enough to suggest that the economy is expanding at a solid pace despite sharp gyrations in the stock market. The Labor Department says that the unemployment rate remained 3.7%, nearly a five-decade low, for the third straight month. Average hourly pay rose 3.1% from a year ago, matching the previous month’s figure, which was the best since 2009.___Chinese executive facing US extradition appears in courtVANCOUVER, British Columbia (AP) — A prominent Chinese telecommunications executive facing possible extradition to the United States appears in court Friday as she seeks bail in a case that has rattled markets and raised doubts about the U.S. being able to reach a truce in its trade war with China.___Meng Wanzhou’s rise through the ranks at HuaweiNEW YORK (AP) — Before her dramatic arrest in Canada, few in the U.S. had heard of Meng Wanzhou. She’s the chief financial officer and deputy chairwoman of the board of Chinese telecom company Huawei. She started there in 1993 and has risen up the ranks with the growth of the company, which is founded by her father.___Stocks drop 4 per cent in rocky week on trade, growth worriesNEW YORK (AP) — Wall Street capped a turbulent week of trading Friday with the biggest weekly loss for the U.S. stock market since March. The latest wave of selling erased more than 550 points from the Dow Jones Industrial Average, bringing its three-day loss to 1,400. Worries that the U.S.-China trade dispute and rising interest rates will pump the brakes on global economic and corporate earnings growth next year has made investors uneasy, leading to volatile swings in the market from one day to the next.___Oil producers join forces and cut production againVIENNA (AP) — Oil prices spiked sharply higher Friday as major oil producers, including the OPEC cartel, agreed to cut global oil production by 1.2 million barrels a day to reduce oversupply. Following two days of meetings, the Organization of the Petroleum Exporting Countries that includes the likes of Saudi Arabia and Iraq said they would cut 800,000 barrels per day for six months from January, though some countries such as Iran, have been given an exemption.___Marlboro maker places $1.8 billion bet on marijuanaNEW YORK (AP) — One of the world’s biggest tobacco companies is diving into the cannabis market with a $1.8 billion buy-in. Marlboro maker Altria is taking a 45 per cent stake in Cronos Group, the Canadian medical and recreational marijuana provider, which said that the investment could grow. According to terms released Friday, Altria’s investment would be similar to that of Corona maker Constellation Brands, which invested about $4 billion in another pot company earlier this year.___Australia anti-encryption law rushed to passageMELBOURNE, Australia (AP) — A new law rushed through Australia’s parliament will compel technology companies including Apple, Facebook and Google to help police catch terrorists and other criminals by disabling encryption protections. Cybersecurity experts say the law will instead be a boon to the criminal underworld by undermining the internet’s technical integrity, weakening digital security and privacy.___France girds for weekend protests, fearing more violencePARIS (AP) — Anticipating a fourth straight weekend of violent protests, France is mobilizing thousands of police, cordoning off Paris’ broad boulevards and making plans to shut down tourist sites like the Eiffel Tower and the Louvre. The heavy security will put central Paris in a virtual lockdown Saturday against what the interior minister called “radicalized and rebellious people,” who authorities believe will join members of the “yellow vest” movement that has been holding anti-government demonstrations.___Foie gras off Amazon’s offerings in California in settlementLOS ANGELES (AP) — California prosecutors say Amazon has agreed not to sell foie gras in the state from birds that have been force-fed. State lawmakers banned that form of the fatty duck and goose liver delicacy nearly 15 years ago. Prosecutors said Friday a state judge approved a settlement between the online retailer, her office and district attorneys in Monterey and Santa Clara counties. Amazon said the company is not commenting.___The S&P 500 index fell 62.87 points, or 2.3 per cent, to 2,633.08. The Dow Jones Industrial Average dropped 558.72 points, or 2.2 per cent, to 24,388.95. The Nasdaq composite slid 219.01 points, or 3 per cent, to 6,969.25. The Russell 2000 index of small-company stocks gave up 29.32 points, or 2 per cent, to 1,448.09.U.S. benchmark crude rose 2.2 per cent to $52.61 a barrel in New York. Brent crude, used to price international oils, gained 2.7 per cent to $61.67 a barrel in London. Wholesale gasoline climbed 3.7 per cent to $1.49 a gallon. Heating oil rose 1.5 per cent to $1.89 a gallon. Natural gas gained 3.7 per cent to $4.49 per 1,000 cubic feet.The Associated Presslast_img read more

Northern Development to host free webinars for small businesses

first_imgFORT ST. JOHN, B.C. – Northern Development will be hosting free web seminars geared towards small businesses.Northern Development is encouraging businesses that are associated with Love Northern B.C., Supply Chain Connector and Community Futures to register and access dozens of premier practical business education seminars for free.According to Northern Development, the Small Business B.C. webinars provide up-to-date information and tactics on current business trends and strategies designed to help small businesses improve, succeed and remain competitive, which can have an immediate impact on business operations. Some of the upcoming webinars will focus on sales strategies and blogging to promote your business.For more information on the upcoming Small Business B.C. webinars, you can visit Northern Development’s website.last_img read more

Algerias Bouteflika back home but health fears remain

first_imgALGIERS – Veteran Algerian president Abdelaziz Bouteflika flew home Thursday after a Paris medical check-up that had raised questions about his ability to run for a fourth term in April.Bouteflika, 76, has ruled the north African nation continuously since 1999 but a mini-stroke that confined him to a Paris hospital for three months last year has created concerns for the political future of a country seen as pivotal to the fight against Al-Qaeda across the Sahara.The president’s office had insisted that the check-up was entirely routine and Algeria’s APS news agency reported that it had found an “an overall improvement” in his health that had enabled him to return home earlier than planned. Bouteflika has until Sunday to convene the organising committee for April’s election in which the ruling National Liberation Front (FLN) named him as its candidate in November despite his failing health.Bouteflika’s presidency has been dogged by health concerns since as far back as 2005, when he underwent surgery in Paris for a bleeding stomach ulcer, and with a leaked US diplomatic cable two years later suggesting he might be suffering from terminal cancer.The transient ischaemic attack, or mini-stroke, that he suffered last April kept him out of the country until late July and he has not been seen in public since.But he has never named a favoured successor and has not ruled out the possibility of accepting the FLN’s nomination to stand for re-election, creating mounting political uncertainty.Opposition parties have seized on his latest hospitalisation as evidence that he is incapable of carrying out his duties, let alone standing for a fourth term.“It proves once again his inability to accomplish the least of his duties, and encourages those calling for him to be declared incapacitated as stipulated by Article 88 of the constitution,” said Atmane Mazouz, spokesman for the mainly Berber Rally for Culture and Democracy.Bouteflika’s opponents had insisted the constitutional clause be invoked in April but had little chance of mustering the necessary two-thirds majority in parliament, which is dominated by the FLN.The FLN nominated the ageing president as its official candidate in November and the party’s secretary general Amar Saidani said on Sunday that he was “sure” he would run.last_img read more

Latest transfer talk

first_imgHere are some of the latest transfer news and rumours from around Europe.Andre Gomes Despite playing under the guidance of a different manager, the out-of-favour Portuguese midfielder has had a second underwhelming season at Barcelona. He was never a good buy as he doesn’t fit the style of play the team from Catalonia dictates. It’s safe to assume that Andre Gomes is on his way out and the latest club that has been attached to his name is Tottenham Hotspur.Rafinha Barcelona’s midfielder is on loan at Inter and the Italian side is reported to be interested in making the deal permanent. All that’s needed now is for a fee to be agreed upon.Kylian Mbappe, Paris Saint-GermainKylian Mbappe could return to PSG training next week Andrew Smyth – September 12, 2019 Paris Saint-Germain confirmed that Kylian Mbappe could make a return to training to next week as he continues to recover from a hamstring injury.Bernd Leno By acquiring Eintracht Frankfurt’s Lukas Hradecky, Bayer Leverkusen is preparing for life without its primary goalkeeper. A release clause of only €20 million will make the German one of the most popular targets on the market. Arsenal appears to be the most interested club at the moment, with Napoli (Pepe Reina is on his way to AC Milan) and Atletico Madrid (who might lose Oblak to PSG) are following suit.Edinson Cavani The Uruguayan might be nearing the end of his spell in France and Juventus is believed to be paying close attention. Higuain is aging, so The Old Lady is definitely in need of a world-class refreshment up front. What better than one of the most prolific strikers in Europe?Leander Dendoncker The 23-year-old Belgian is ripe for a bigger challenge than the Jupiler League. He is reportedly ready to move on and several clubs are interested in his services, starting with Atletico Madrid. Crystal Palace and West Ham are two other teams believed to be in on the holding midfielder who can also play center back. The “only” problem might be the over-the-top asking price of over €23 million.last_img read more

Ruben LoftusCheek I need to be patient at Chelsea

first_imgChelsea midfielder Ruben Loftus-Cheek admits that patience is required for first-team chances under coach Maurizio SarriThe England international was denied another loan move from Stamford Bridge this summer by Sarri and has made just two substitute appearances in Chelsea’s four Premier League games.Jorginho, N’Golo Kante, Ross Barkley and Mateo Kovacic are all ahead of Loftus-Cheek in the pecking order at Chelsea.However, despite the continued struggles with the Blues, Loftus-Cheek has managed to retain his place in the England squad.But more first-team football is essential if the 22-year-old is to continue his development.“Being 22 feels quite old, considering some of the boys were playing when they were 17 or 18. I’d like to have more appearances by now, but it’s just the way my journey has gone, and I just have to be patient with it,” he told Sky Sports.“I can see it as a positive; I’m playing for England, playing well when I play, and that’s without too many appearances so it’s still raw in that sense.”He added: “Being at Chelsea, it’s a top club with top players. When I’m training at 17 or 18 with the first team, it was really good for my education playing with these top players.“I really enjoyed playing and training with them, I could feel myself getting better every day and improving, but it got to a point where training wasn’t enough and you need the exposure in the Premier League.”Here’s some of @rubey_lcheek​ best bits for August Cristiano Ronaldo, Nemanja Vidic, Manchester UnitedVidic: “Ronaldo is the most professional footballer I’ve seen” Andrew Smyth – September 14, 2019 Nemanja Vidic opened up on how a 21-year-old Cristiano Ronaldo’s professionalism left him stunned at Manchester United.— Crystal Palace F.C. (@CPFC) September 8, 2017Loftus-Cheek managed two goals and four assists in 24 league appearances on loan at Crystal Palace last season.“That’s when I took the chance to go to Palace, and even when that happened, I thought I could’ve done it earlier,” he continued.“I started really enjoying my football, playing in the Premier League every week, and I felt the benefits.“The benefit of last season at Palace [was first-team football]. I was fortunate enough to be fit for that period where it’s like a game every three days over Christmas, and I got my body used to being able to play, have a rest, then play on a Tuesday.“That was massive for me and I coped with it well.”Loftus-Cheek has a contract at Chelsea until June 2021.Although he’s only made 13 starts at Chelsea since making his first-team debut in 2014.last_img read more